Mj. Shelton et al., Effects of grapefruit juice on pharmacokinetic exposure to indinavir in HIV-positive subjects, J CLIN PHAR, 41(4), 2001, pp. 435-442
The objective of this study was to determine the effects of double-strength
grapefruit juice on gastric pH and systemic bioavailability of indinavir i
n HN-infected subjects receiving indinavir. Fourteen HN-infected subjects t
ook 800 mg of indinavir with 6 ounces (180 mi) of water or double-strength
grapefruit juice. Gastric pH was measured and blood samples were collected
for 5 hours after indinavir dosing. Grapefruit juice increased the mean gas
tric pH (from 1.39 +/- 0.4 to 3.20 +/- 0.3; p < 0.05) and slightly delayed
the absorption of indinavir (t(max) increased from 1.12 +/- 0.8 h to 1.56 /- 0.6 h; p < 0.05). However, there were no significant differences in indi
navir exposure. C,, was 16.7 +/- 7.3 muM with water versus 13.9 +/- 4.2 muM
with grapefruit juice (p = NS), and AUC(0.8) was 37.5 +/- 19 with water ve
rsus 36.9 +/- 15 with grapefruit juice (p = NS). The authors concluded that
concomitant administration of grapefruit juice increases gastric pH and de
lays indinavir absorption but does not uniformly affect the systemic bioava
ilability of indinavir in HN-infected subjects. (C) 2001 the American Colle
ge of Clinical Pharmacology.